<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35295746</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2405-6502</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>eNeurologicalSci</Title>
          <ISOAbbreviation>eNeurologicalSci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Thymoma-associated anti-LGI1 encephalitis and myasthenia gravis: A unique combination with autoantibodies.</ArticleTitle>
        <Pagination>
          <StartPage>100395</StartPage>
          <MedlinePgn>100395</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">100395</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ensci.2022.100395</ELocationID>
        <Abstract>
          <AbstractText>We report a 77-year-old woman with a thymoma, anti-LGI1antibody associated encephalitis (LGI1 encephalitis), and MG accompanied by positive anti-acetylcholine receptor antibodies (AchR Ab) and anti-titin antibodies (titin Ab). She was treated with thymomectomy followed by immunosuppressive therapy, which resulted in immediate amelioration of motor weakness and gradual improvement of cognitive impairment over the next two years. LGI1 Ab were positive at two months after thymomectomy, followed by negative conversion demonstrated on 1 year examination. The AchR Ab level had gradually decreased but titin Ab was positive on re-examination after two years, although the cognition and motor impairment symptoms had been alleviated. In patients with suspected autoimmune encephalitis, the detection of several autoantibodies including LGI1 and thymomas provides useful information for making an accurate diagnosis.</AbstractText>
          <CopyrightInformation>© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Satake</LastName>
            <ForeName>Akane</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Faculty of Medicine, University of Yamanashi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nagasaka</LastName>
            <ForeName>Takamura</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Faculty of Medicine, University of Yamanashi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kurita</LastName>
            <ForeName>Takafumi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Faculty of Medicine, University of Yamanashi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murata</LastName>
            <ForeName>Hiroaki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Faculty of Medicine, University of Yamanashi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hata</LastName>
            <ForeName>Takanori</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Faculty of Medicine, University of Yamanashi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shinmura</LastName>
            <ForeName>Hiroyuki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Kofu Kyoritsu Hospital, Yamanashi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matsubara</LastName>
            <ForeName>Hirochika</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Faculty of Medicine, University of Yamanashi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shindo</LastName>
            <ForeName>Kazumasa</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Faculty of Medicine, University of Yamanashi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takiyama</LastName>
            <ForeName>Yoshihisa</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Faculty of Medicine, University of Yamanashi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>eNeurologicalSci</MedlineTA>
        <NlmUniqueID>101667077</NlmUniqueID>
        <ISSNLinking>2405-6502</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Anti-LGI1 encephalitis</Keyword>
        <Keyword MajorTopicYN="N">Myasthenia gravis</Keyword>
        <Keyword MajorTopicYN="N">Myokymia</Keyword>
        <Keyword MajorTopicYN="N">Thymoma</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>17</Day>
          <Hour>5</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35295746</ArticleId>
        <ArticleId IdType="pmc">PMC8919234</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ensci.2022.100395</ArticleId>
        <ArticleId IdType="pii">S2405-6502(22)00004-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bernard C., Frih H., Pasquet F., Kerever S., Jamilloux Y., Tronc F., Guibert B., Isaac S., Devouassoux M., Chalabreysse L., Broussolle C., Petiot P., Girard N., Sève P. Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun. Rev. 2016;15:82–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26408958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evoli A., Minicuci G.M., Vitaliani R., Battaglia A., Della Marca G., Lauriola L., Fattorossi A. Paraneoplastic diseases associated with thymoma. J. Neurol. 2007;254:756–762.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17325820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irani S.R., Alexander S., Waters P., Kleopa K.A., Pettingill P., Zuliani L., Vincent A. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain. 2010;133:2734–2748.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2929337</ArticleId>
            <ArticleId IdType="pubmed">20663977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Sonderen A., Thijs R.D., Coenders E.C., Jiskoot L.C., Sanchez E., de Bruijn M.A.A.M., van Coevorden-Hameete M.H., Wirtz P.W., Schreurs M.W.J., Smitt P.A.E.S., Titulaer M.J. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology. 2016;87:1449–1456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27590293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guasp M., Landa J., Martinez-Hernandez E., Sabater L., Iizuka T., Simabukuro M., Nakamura M., Kinoshita M., Kurihara M., Kaida K., Bruna J., Kapetanovic S., Sánchez P., Ruiz-García R., Naranjo L., Planagumà J., Muñoz-Lopetegi A., Bataller L., Saiz A., Dalmau J., Graus F. Thymoma and autoimmune encephalitis: clinical manifestations and antibodies. Neurol. Neuroimmunol. Neuroinflamm. 2021;8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8312280</ArticleId>
            <ArticleId IdType="pubmed">34301822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hor J.Y., Lim T.T., Cheng M.C., Chia Y.K., Wong C.K., Lim S.M., Cheah C.F., Tan K., Easaw P.E.S., Leite M.I. Thymoma-associated myasthenia gravis and LGI1-encephalitis, with nephrotic syndrome post-thymectomy. J. Neuroimmunol. 2018;317:100–102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29395322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berger B., Stich O., Labeit S., Rauer S. Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes. J. Neuroimmunol. 2016;295-296:18–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27235344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X., Mao Y.T., Wu J.J., Li L.X., Chen X.J. Anti-AMPA receptor encephalitis associated with thymomatous myasthenia gravis. J. Neuroimmunol. 2015;281:35–37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25867465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao Y., Li X., Lin J., Zhang X., Wang H. Thymoma-associated autoimmune encephalitis with positive Titin antibodies: a case report. J. Neuroimmunol. 2021;358</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34325343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vogrig A., Pauletto G., Belgrado E., Pegolo E., Di Loreto C., Rogemond V., Honnorat J., Eleopra R. Effect of thymectomy on refractory autoimmune status epilepticus. J. Neuroimmunol. 2018;317:90–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29336839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez A., Klein C.J., Sechi E., Alden E., Basso M.R., Pudumjee S., Pittock S.J., McKeon A., Britton J.W., Lopez-Chiriboga A.S., Zekeridou A., Zalewski N.L., Boeve B.F., Day G.S., Gadoth A., Burkholder D., Toledano M., Dubey D., Flanagan E.P. LGI1 antibody encephalitis: acute treatment comparisons and outcome. J. Neurol. Neurosurg. Psychiatry. 2022;93:309–315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8862031</ArticleId>
            <ArticleId IdType="pubmed">34824144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graus F., Vogrig A., Muñiz-Castrillo S., Antoine J.G., Desestret V., Dubey D., Giometto B., Irani S.R., Joubert B., Leypoldt F., McKeon A., Prüss H., Psimaras D., Thomas L., Titulaer M.J., Vedeler C.A., Verschuuren J.J., Dalmau J., Honnorat J. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol. Neuroimmunol. Neuroinflamm. 2021;8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8237398</ArticleId>
            <ArticleId IdType="pubmed">34006622</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
